Genetic biomarkers for ALS disease in transgenic SOD1(G93A) mice.
The pathophysiological mechanisms of both familial and sporadic Amyotrophic Lateral Sclerosis (ALS) are unknown, although growing evidence suggests that skeletal muscle tissue is a primary target of ALS toxicity. Skeletal muscle biopsies were performed on transgenic SOD1(G93A) mice, a mouse model of...
Guardado en:
Autores principales: | Ana C Calvo, Raquel Manzano, Gabriela Atencia-Cibreiro, Sara Oliván, María J Muñoz, Pilar Zaragoza, Pilar Cordero-Vázquez, Jesús Esteban-Pérez, Alberto García-Redondo, Rosario Osta |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2012
|
Materias: | |
Acceso en línea: | https://doaj.org/article/0b29545086dd470c8e4430df219cdfb0 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Locus-specific analysis of Transposable Elements during the progression of ALS in the SOD1G93A mouse model.
por: Braulio Valdebenito-Maturana, et al.
Publicado: (2021) -
Altered Metabolic Profiles Associate with Toxicity in SOD1G93A Astrocyte-Neuron Co-Cultures
por: Gabriel N. Valbuena, et al.
Publicado: (2017) -
The GLP-1 receptor agonist, liraglutide, fails to slow disease progression in SOD1G93A and TDP-43Q331K transgenic mouse models of ALS
por: Amy Keerie, et al.
Publicado: (2021) -
Downregulating carnitine palmitoyl transferase 1 affects disease progression in the SOD1 G93A mouse model of ALS
por: Michael Sloth Trabjerg, et al.
Publicado: (2021) -
Overexpression of ferroptosis defense enzyme Gpx4 retards motor neuron disease of SOD1G93A mice
por: Liuji Chen, et al.
Publicado: (2021)